Noninvasive Pressure-Volume Loops Predict Major Adverse Cardiac Events in Heart Failure With Reduced Ejection Fraction.

Per M Arvidsson, Jonathan Berg, Marcus Carlsson, H��kan Arheden
Author Information
  1. Per M Arvidsson: Department of Clinical Sciences Lund, Clinical Physiology, Sk��ne University Hospital, Lund University, Lund, Sweden.
  2. Jonathan Berg: Department of Clinical Sciences Lund, Clinical Physiology, Sk��ne University Hospital, Lund University, Lund, Sweden.
  3. Marcus Carlsson: Department of Clinical Sciences Lund, Clinical Physiology, Sk��ne University Hospital, Lund University, Lund, Sweden.
  4. H��kan Arheden: Department of Clinical Sciences Lund, Clinical Physiology, Sk��ne University Hospital, Lund University, Lund, Sweden.

Abstract

Background: Heart failure with reduced ejection fraction (HFrEF) is characterized by ventricular remodeling and impaired myocardial energetics. Left ventricular pressure-volume (PV) loop analysis can be performed noninvasively using cardiovascular magnetic resonance (CMR) imaging to assess cardiac thermodynamic efficiency.
Objectives: The aim of the study was to investigate whether noninvasive PV loop parameters, derived from CMR, could predict major adverse cardiac events (MACE) in HFrEF patients.
Methods: PV loop parameters (stroke work, ventricular efficiency, external power, contractility, and energy per ejected volume) were computed from CMR cine images and brachial blood pressure. The primary end point was MACE (cardiovascular death, heart failure (HF) hospitalization, myocardial infarction, revascularization, ventricular tachycardia/fibrillation, heart transplantation, or left ventricular assist device implantation within 5 years). Associations between PV loop parameters and MACE were evaluated using multivariable Cox regression.
Results: One hundred and sixty-four HFrEF patients (left ventricular ejection fraction ���40%, age 63 [IQR: 55-70] years, 79% male) who underwent clinical CMR examination between 2004 and 2014 were included. Eighty-eight patients (54%) experienced at least one MACE after an average of 2.8 years. Unadjusted models demonstrated a significant association between MACE and all PV loop parameters ( < 0.05 for all), HF etiology ( < 0.001), left ventricular ejection fraction ( = 0.003), global longitudinal strain ( < 0.001), and N-terminal prohormone of brain natriuretic peptide level ( = 0.001). In the multivariable Cox regression analysis adjusted for age, sex, hypertension, diabetes, and HF etiology, ventricular efficiency was associated with MACE (HR: 1.04 (95% CI: 1.01-1.08) per-% decrease,  = 0.01).
Conclusions: Ventricular efficiency, derived from noninvasive PV loop analysis from standard CMR scans, is associated with MACE in patients with HFrEF.

Keywords

References

  1. Circ Cardiovasc Imaging. 2013 Mar 1;6(2):329-38 [PMID: 23258478]
  2. JACC Cardiovasc Imaging. 2018 Sep;11(9):1274-1284 [PMID: 29680351]
  3. Circulation. 1977 Nov;56(5):845-52 [PMID: 71960]
  4. Am J Cardiol. 1979 May;43(5):969-74 [PMID: 433779]
  5. Circulation. 2012 Mar 27;125(12):1511-9 [PMID: 22368152]
  6. Circulation. 2020 Apr 7;141(14):1152-1163 [PMID: 32138541]
  7. PLoS One. 2015 May 15;10(5):e0127044 [PMID: 25978372]
  8. N Engl J Med. 2014 Sep 11;371(11):993-1004 [PMID: 25176015]
  9. Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):808-13 [PMID: 15647364]
  10. Sci Rep. 2022 Apr 4;12(1):5611 [PMID: 35379859]
  11. Cardiovasc Res. 2023 Oct 16;119(12):2230-2243 [PMID: 36734080]
  12. Eur Heart J. 2005 Nov;26(22):2404-12 [PMID: 16105848]
  13. Am J Cardiol. 1977 Nov;40(5):748-53 [PMID: 920611]
  14. J Cardiovasc Magn Reson. 2022 Nov 7;24(1):53 [PMID: 36336693]
  15. Physiol Rev. 1990 Apr;70(2):247-77 [PMID: 2181496]
  16. Am Heart J. 2022 Apr;246:117-124 [PMID: 35045326]
  17. Circ Cardiovasc Imaging. 2020 Apr;13(4):e010105 [PMID: 32312112]
  18. Sci Rep. 2021 Oct 13;11(1):20280 [PMID: 34645886]
  19. BMC Med Imaging. 2010 Jan 11;10:1 [PMID: 20064248]
  20. Circulation. 2023 May 30;147(22):1654-1669 [PMID: 37070436]
  21. N Engl J Med. 2007 Mar 15;356(11):1140-51 [PMID: 17360992]
  22. ESC Heart Fail. 2022 Aug;9(4):2313-2324 [PMID: 35411699]
  23. Circulation. 2023 Jul 11;148(2):109-123 [PMID: 37199155]
  24. Circulation. 1992 Aug;86(2):513-21 [PMID: 1638719]
  25. Am J Physiol. 1979 Mar;236(3):H498-505 [PMID: 426086]
  26. J Cardiovasc Magn Reson. 2013 Oct 24;15:96 [PMID: 24156367]
  27. Circ Res. 1973 Mar;32(3):314-22 [PMID: 4691336]
  28. Am J Cardiol. 2022 Dec 1;184:48-55 [PMID: 36192197]
  29. Eur Heart J Imaging Methods Pract. 2023 Oct 25;1(2):qyad035 [PMID: 37969333]
  30. Int J Cardiovasc Imaging. 2022 Apr;38(4):853-861 [PMID: 34787731]
  31. J Cardiovasc Magn Reson. 2023 Jan 16;25(1):1 [PMID: 36642713]
  32. Heart. 2014 Nov;100(21):1673-80 [PMID: 24860005]
  33. Heart. 2009 Sep;95(17):1429-35 [PMID: 19414439]
  34. PLoS One. 2023 May 10;18(5):e0285592 [PMID: 37163493]
  35. Circulation. 1999 Jul 20;100(3):243-9 [PMID: 10411847]
  36. Eur Heart J. 2021 Sep 21;42(36):3599-3726 [PMID: 34447992]
  37. Sci Rep. 2023 Jan 21;13(1):1216 [PMID: 36681759]
  38. Clin Physiol Funct Imaging. 2021 Sep;41(5):467-470 [PMID: 34121316]
  39. Am J Med Sci. 1987 Mar;293(3):159-63 [PMID: 3565462]
  40. Circ Cardiovasc Imaging. 2019 Dec;12(1):e008493 [PMID: 30630347]
  41. J Cardiovasc Magn Reson. 2018 Dec 10;20(1):81 [PMID: 30526611]
  42. J Am Coll Cardiol. 2018 Nov 6;72(19):2360-2379 [PMID: 30384893]

Word Cloud

Created with Highcharts 10.0.0ventricularloopMACEPVCMRHFrEFanalysisefficiencyparameterspatientsfailureejectioncardiovascularnoninvasiveheartHFleft< 0001 = 0fractionmyocardialpressure-volumeusingmagneticresonanceimagingcardiacderivedmultivariableCoxregressionageetiologyassociated1Background:HeartreducedcharacterizedremodelingimpairedenergeticsLeftcanperformednoninvasivelyassessthermodynamicObjectives:aimstudyinvestigatewhetherpredictmajoradverseeventsMethods:strokeworkexternalpowercontractilityenergyperejectedvolumecomputedcineimagesbrachialbloodpressureprimaryendpointdeathhospitalizationinfarctionrevascularizationtachycardia/fibrillationtransplantationassistdeviceimplantationwithin5 yearsAssociationsevaluatedResults:Onehundredsixty-fourfraction ���40%63[IQR:55-70]years79%maleunderwentclinicalexamination20042014includedEighty-eight54%experiencedleastoneaverage28 yearsUnadjustedmodelsdemonstratedsignificantassociation05003globallongitudinalstrainN-terminalprohormonebrainnatriureticpeptideleveladjustedsexhypertensiondiabetesHR:0495% CI:01-108per-%decrease01Conclusions:VentricularstandardscansNoninvasivePressure-VolumeLoopsPredictMajorAdverseCardiacEventsin Heart FailureReducedEjection Fractionoutcome

Similar Articles

Cited By